Shares of Eli Lilly (LLY) are moving higher on Tuesday morning as the company reported its first-quarter earnings results, revealing a 26% year-over-year...
) are moving higher on Tuesday morning as the company reported its first-quarter earnings results, revealing a 26% year-over-year revenue increase in a figure of $8.77 billion. Ultimately, this revenue print fell short of estimates .
Shopify stock was climbing Monday after an analyst upgraded shares of the e-commerce platform on confidence in growth. Citi analyst Tyler Radke upgraded shares of Shopify to Buy from Neutral, and increased his target price to $105 from $93, which implies a 47% increase in the stock price as of Friday’s close. “Our Deep-Dive analysis into SHOP’s Merchant Solutions business gives us confidence in SHOP’s long-term growth,” Radke wrote in a research note.
Tony Robbins is an expert on building wealth, but he didn't get there overnight. He spent years working with and learning from some of the most successful investors of all time -- including hedge...The Canadian dollar edged up to a near three-week high against its U.S. counterpart on Monday as risk sentiment improved and ahead of monthly GDP data this week that could offer clues on the strength of the domestic economy. The loonie was trading 0.1% higher at 1.3656 to the U.S. dollar, or 73.
OTTAWA -Canada's economy likely weakened in the first quarter, data from Statistics Canada showed on Tuesday, bolstering expectations that the Canadian central bank would have more reason to cut interest rates in June. Canada's gross domestic product rose 0.2% in February, less than analysts' estimates, while growth in March likely remained muted, Statistics Canada said.
Revenue Increase Pharmaceutical Giant
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly's GLP-1 demand drives up stock price post-Q1 resultsShares of Eli Lilly (LLY) are soaring in Tuesday's trading session after the company raised its full-year guidance, driven by the surging demand for its...
Read more »
Eli Lilly's weight loss drug could help sleep apnea patientsShares of Eli Lilly (LLY) are slightly above their flatline Wednesday morning after the pharmaceutical giant announced positive results from a clinical trial...
Read more »
Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman SaysThe weight loss drug frenzy that’s driven Eli Lilly & Co. and Novo Nordisk A/S to record peaks is raising the stakes for investors, according to Goldman Sachs Group Inc. analysts.
Read more »
Weight loss drugs and the many use cases in medical treatmentsNovo Nordisk's (NVO) Ozempic and Wegouvy and Eli Lilly's (LLY) Zepbound are the leading names in the latest GLP-1 weight loss drug cycle, a trend that has...
Read more »
Weight-loss drug shortage result of 'unprecedented demand'Certain doses of Eli Lilly's (LLY) GLP-1 weight loss drugs Zepbound and Mounjaro are facing a supply shortage, much like competitor Novo Nordisk's (NVO) own ...
Read more »
Demand for weight-loss drug drives Eli Lilly to raise 2024 sales forecast by US$2-billionEli Lilly said it expects significant production increases in the second half of the year for its obesity treatment and related diabetes drug Mounjaro
Read more »